FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026465106> ?p ?o ?g. }

• W2026465106 endingPage "S143" @default.
• W2026465106 startingPage "S138" @default.
• W2026465106 abstract "A multicenter, randomized Phase 2 study that compared patients, affected by colorectal liver metastases, who received intrahepatic arterial infusion with two different schedules of cisplatin, bolus vs. continuous infusion, and systemic 5-fluorouracil.The aim of this study was to validate results of a previous Phase 2 trial on bolus cisplatin intrahepatic arterial infusion, which reported a 47 percent response rate and a 32 percent 4-year survival rate for Gennari's Stage 2 patients, with a high rate of neurologic, gastrointestinal, and hematologic toxicity.One hundred nine patients were randomized in a Phase 2 study to receive cisplatin intrahepatic arterial infusion (24 mg/m2/day, 1-->5, bolus vs. continuous infusion) and systemic intravenous 5-fluorouracil (250, 375, or 500 mg/m2/day, 1-->5; escalating doses, respectively, at cycles I, II, III, and VI). To avoid neurotoxicity a maximum of six cycles was administered.Preliminary results for the 78 evaluable patients are similar to those of the previous study: response rate 46 percent and at a median follow-up of 16.5 months, the overall survival was 16.5 months, with 45 percent of the patients who received more than 3 cycles alive at 3 years. Toxicity, evaluable in 99 patients, showed a decreased incidence of neurotoxicity and a tolerable gastrointestinal and hematologic toxicity, lower in the cisplatin continuous infusion arm.This study clearly shows that cisplatin intrahepatic arterial infusion is able to provide a good palliative effect with a tolerable toxicity." @default.
• W2026465106 created "2016-06-24" @default.
• W2026465106 creator A5004082860 @default.
• W2026465106 creator A5007262082 @default.
• W2026465106 creator A5013802235 @default.
• W2026465106 creator A5023680398 @default.
• W2026465106 creator A5054196966 @default.
• W2026465106 creator A5068950126 @default.
• W2026465106 creator A5069182888 @default.
• W2026465106 creator A5071185531 @default.
• W2026465106 creator A5076129938 @default.
• W2026465106 creator A5085638542 @default.
• W2026465106 creator A5086743021 @default.
• W2026465106 creator A5091286114 @default.
• W2026465106 date "1994-02-01" @default.
• W2026465106 modified "2023-10-16" @default.
• W2026465106 title "Bolus vs. continuous hepatic arterial infusion of cisplatin plus intravenous 5-fluorouracil chemotherapy for unresectable colorectal metastases" @default.
• W2026465106 cites W1823144309 @default.
• W2026465106 cites W1835268604 @default.
• W2026465106 cites W1986149669 @default.
• W2026465106 cites W1988253031 @default.
• W2026465106 cites W2014738532 @default.
• W2026465106 cites W2028428596 @default.
• W2026465106 cites W2044224410 @default.
• W2026465106 cites W2054075655 @default.
• W2026465106 cites W2075962633 @default.
• W2026465106 cites W2081136240 @default.
• W2026465106 cites W2084411560 @default.
• W2026465106 cites W2105778469 @default.
• W2026465106 cites W2122364701 @default.
• W2026465106 cites W2128813634 @default.
• W2026465106 cites W2144825902 @default.
• W2026465106 cites W2145178317 @default.
• W2026465106 cites W2202530793 @default.
• W2026465106 cites W2325921774 @default.
• W2026465106 cites W2337445781 @default.
• W2026465106 cites W2602544133 @default.
• W2026465106 doi "https://doi.org/10.1007/bf02048447" @default.
• W2026465106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8313786" @default.
• W2026465106 hasPublicationYear "1994" @default.
• W2026465106 type Work @default.
• W2026465106 sameAs 2026465106 @default.
• W2026465106 citedByCount "10" @default.
• W2026465106 countsByYear W20264651062019 @default.
• W2026465106 countsByYear W20264651062022 @default.
• W2026465106 crossrefType "journal-article" @default.
• W2026465106 hasAuthorship W2026465106A5004082860 @default.
• W2026465106 hasAuthorship W2026465106A5007262082 @default.
• W2026465106 hasAuthorship W2026465106A5013802235 @default.
• W2026465106 hasAuthorship W2026465106A5023680398 @default.
• W2026465106 hasAuthorship W2026465106A5054196966 @default.
• W2026465106 hasAuthorship W2026465106A5068950126 @default.
• W2026465106 hasAuthorship W2026465106A5069182888 @default.
• W2026465106 hasAuthorship W2026465106A5071185531 @default.
• W2026465106 hasAuthorship W2026465106A5076129938 @default.
• W2026465106 hasAuthorship W2026465106A5085638542 @default.
• W2026465106 hasAuthorship W2026465106A5086743021 @default.
• W2026465106 hasAuthorship W2026465106A5091286114 @default.
• W2026465106 hasConcept C121608353 @default.
• W2026465106 hasConcept C126322002 @default.
• W2026465106 hasConcept C126894567 @default.
• W2026465106 hasConcept C141071460 @default.
• W2026465106 hasConcept C2776283816 @default.
• W2026465106 hasConcept C2776694085 @default.
• W2026465106 hasConcept C2778239845 @default.
• W2026465106 hasConcept C2778405590 @default.
• W2026465106 hasConcept C2780456651 @default.
• W2026465106 hasConcept C29730261 @default.
• W2026465106 hasConcept C42219234 @default.
• W2026465106 hasConcept C43376680 @default.
• W2026465106 hasConcept C526805850 @default.
• W2026465106 hasConcept C71924100 @default.
• W2026465106 hasConcept C90924648 @default.
• W2026465106 hasConceptScore W2026465106C121608353 @default.
• W2026465106 hasConceptScore W2026465106C126322002 @default.
• W2026465106 hasConceptScore W2026465106C126894567 @default.
• W2026465106 hasConceptScore W2026465106C141071460 @default.
• W2026465106 hasConceptScore W2026465106C2776283816 @default.
• W2026465106 hasConceptScore W2026465106C2776694085 @default.
• W2026465106 hasConceptScore W2026465106C2778239845 @default.
• W2026465106 hasConceptScore W2026465106C2778405590 @default.
• W2026465106 hasConceptScore W2026465106C2780456651 @default.
• W2026465106 hasConceptScore W2026465106C29730261 @default.
• W2026465106 hasConceptScore W2026465106C42219234 @default.
• W2026465106 hasConceptScore W2026465106C43376680 @default.
• W2026465106 hasConceptScore W2026465106C526805850 @default.
• W2026465106 hasConceptScore W2026465106C71924100 @default.
• W2026465106 hasConceptScore W2026465106C90924648 @default.
• W2026465106 hasIssue "2" @default.
• W2026465106 hasLocation W20264651061 @default.
• W2026465106 hasLocation W20264651062 @default.
• W2026465106 hasOpenAccess W2026465106 @default.
• W2026465106 hasPrimaryLocation W20264651061 @default.
• W2026465106 hasRelatedWork W13394025 @default.
• W2026465106 hasRelatedWork W1972380358 @default.
• W2026465106 hasRelatedWork W2047376960 @default.
• W2026465106 hasRelatedWork W2167282749 @default.
• W2026465106 hasRelatedWork W2363409655 @default.

• next